Poster Abstracts
4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.

https://doi.org/10.1016/S2055-6640(20)30709-3Get rights and content
Under a Creative Commons license
open access

Cited by (0)